UPC

Universe Pharmaceuticals INC UPC

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 4 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$17.86B

Quarter to Sep 30

Net income

$-3.67B

Quarter to Sep 30

Free cash flow

$-5.32B

Quarter to Sep 30

Operating margin

-16.3%

Quarter to Sep 30

Top Institutional Holders

as of Q2 2026
$125.5K total
UBS Group AG
$87.6K+1418.7%
OSAIC HOLDINGS, INC.
$37.6KNew
HRT FINANCIAL LP
$103New
Caitong International Asset Management Co., Ltd
$73New
See all 4 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Debt/Equity

FY 2025
EDGAR

Loading ratio trend…

UPC key financials by period

Reported revenue, net income and operating margin by fiscal year, from Universe Pharmaceuticals INC's annual filings on SEC EDGAR.

Universe Pharmaceuticals INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$17.9B$-3.7B-16.3%
FY 2024$23.0B$-8.7B-34.8%
FY 2023$32.3B$-6.6B-12.3%
FY 2022$40.1M$-7.9M-17.5%
FY 2021$48.0M$11.3M28.3%
FY 2020$30.7M$7.6M33.4%
Source: UPC filings on SEC EDGAR →

UPC insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Universe Pharmaceuticals INC (UPC): stock profile, AI score and financials

Universe Pharmaceuticals INC (UPC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. UPC is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 4 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Universe Pharmaceuticals INC reports quarterly revenue of $17.9B, net income of $-3.7B, an operating margin of -16.3%. Top institutional holders of UPC by reported 13-F value include UBS Group AG, OSAIC, HRT FINANCIAL, based on the most recent SEC filings. UPC trades on the Nasdaq exchange and files with the SEC under CIK 1809616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UPC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Universe Pharmaceuticals INC directly from SEC EDGAR.

SEC EDGAR: CIK 1809616 →